| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | KULR | Common Stock | Sale | -$117K | -511K | -3.27% | $0.23 | 15.1M | Mar 21, 2024 | Direct | F1, F2 |
| transaction | KULR | Common Stock | Sale | -$101K | -460K | -3.05% | $0.22 | 14.6M | Mar 22, 2024 | Direct | F1, F3, F4 |
| Id | Content |
|---|---|
| F1 | Dr. Knowles, in order to make proceeds available for extraordinary medical expense obligations, sold shares pursuant to the limitations set forth in Rule 144(e) with respect to the amount of securities eligible for sale during any three month period. |
| F2 | On March 21, 2024, Dr. Knowles, sold 510,598 shares of common stock of the Company at an average price of $0.228863 per share. Upon request by the Commission, the Reporting Person shall provide full information regarding the number of shares sold at each separate price. |
| F3 | On March 22, 2024, Dr. Knowles, sold 460,037 shares of common stock of the Company at an average price of $0.222419 per share. Upon request by the Commission, the Reporting Person shall provide full information regarding the number of shares sold at each separate price. |
| F4 | The number of shares of common stock beneficially owned following the reported transactions does not include Dr. Knowles' indirect ownership of over 670,360 shares owned by his spouse, Marianne Knight. Dr. Knowles does not have direct voting or dispositive control over the shares owned by Ms. Knight. |